Rchr
J-GLOBAL ID：202201001431435273
Update date: Feb. 01, 2024
Ebata Takahiro
エバタ タカヒロ | Ebata Takahiro
Affiliation and department：
Job title：
Assistant Professor
Research field (2)：
Hematology and oncology
, Tumor biology
Research keywords (2)：
エピジェネティクス
, がん
Research theme for competitive and other funds (3)：
- 2023 - 2026 FERMT2メチル化を利用したがん特異的なインテグリン経路阻害薬の開発
- 2020 - 2023 術前化学療法後卵巣がんを用いた治療抵抗性をきたす遺伝子メチル化の同定と機序の解明
- 2014 - 2016 The exploration of the Hedgehog pathway as a treatment target in neuroendocrine carcinoma of the lung.
Papers (28)：
-
Nobuaki Arai, Naoko Hattori, Satoshi Yamashita, Yu-Yu Liu, Takahiro Ebata, Chihiro Takeuchi, Hideyuki Takeshima, Satoshi Fujii, Haruhiko Kondo, Hirofumi Mukai, et al. HSD17B4 methylation enhances glucose dependence of BT-474 breast cancer cells and increases lapatinib sensitivity. Breast Cancer Research and Treatment. 2023
-
Shigehisa Kitano, Yutaka Fujiwara, Toshio Shimizu, Satoru Iwasa, Kan Yonemori, Shunsuke Kondo, Akihiko Shimomura, Takafumi Koyama, Takahiro Ebata, Hiroki Ikezawa, et al. A feasibility study of lenvatinib plus pembrolizumab in Japanese patients with advanced solid tumors. Cancer chemotherapy and pharmacology. 2022. 90. 6. 523-529
-
Takahiro Ebata, Satoshi Yamashita, Hideyuki Takeshima, Hiroshi Yoshida, Yoshiko Kawata, Nao Kino, Toshiharu Yasugi, Yasuhisa Terao, Kan Yonemori, Tomoyasu Kato, et al. DNA methylation of the immediate upstream region of BRCA1 major transcription start sites is an independent favorable prognostic factor in patients with high-grade serous ovarian cancer. Gynecologic oncology. 2022
-
Takahiro Ebata, Satoshi Yamashita, Hideyuki Takeshima, Hiroshi Yoshida, Yoshiko Kawata, Nao Kino, Toshiharu Yasugi, Yasuhisa Terao, Kan Yonemori, Tomoyasu Kato, et al. DNA methylation marker to estimate ovarian cancer cell fraction. Medical oncology (Northwood, London, England). 2022. 39. 5. 78-78
-
Go Saito, Takahiro Ebata, Tsukasa Ishiwata, Shunichiro Iwasawa, Ichiro Yoshino, Yuichi Takiguchi, Koichiro Tatsumi. Risk factors for skeletal-related events in non-small cell lung cancer patients treated with bone-modifying agents. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2021. 29. 7. 4081-4088
ｍore...
MISC (5)：
-
石綿 司, 津島 健司, 寺田 二郎, 多田 裕司, 巽 浩一郎, 江畑 貴大, 岩澤 俊一郎, 滝口 裕一, 松嶋 惇, 中谷 行雄. Nivolumabによるacute fibrinous and organizing pneumonia(AFOP)パターンの薬剤性肺障害 症例報告. 肺癌. 2016. 56. 4. 323-324
-
江畑 貴大, 栗本 遼太, 岩澤 俊一郎, 石綿 司, 滝口 裕一, 多田 裕司, 巽 浩一郎, 増田 渉, 中谷 行雄. 自然消退と増悪を繰り返すALK融合遺伝子陽性非小細胞肺癌の1例. 肺癌. 2016. 56. 3. 248-248
-
江畑 貴大, 栗本 遼太, 岩澤 俊一郎, 滝口 裕一, 石綿 司, 多田 裕司, 巽 浩一郎, 藤原 大樹, 吉野 一郎, 中谷 行雄, et al. 同一病変内に高分化型成分と脱分化型成分を認めた脂肪肉腫の1例. 肺癌. 2016. 56. 1. 74-74
-
堺田 惠美子, 栗本 遼太, 江畑 貴大, 岩澤 俊一郎, 池田 啓, 勝野 達郎, 中島 裕史, 横須賀 收, 中世古 知昭, 滝口 裕一. インフリキシマブ短時間投与の前向き試験. 日本内科学会雑誌. 2016. 105. Suppl. 269-269
-
Tsukasa Ishiwata, Shunichiro Iwasawa, Ryota Kurimoto, Takahiro Ebata, Yuichi Takiguchi. Prophylactic dexamethasone for radiation-induced bone-pain flare. The Lancet. Oncology. 2016. 17. 2. e39-e40-e40
Education (2)：
- 2014 - 2018 Chiba University Graduate School of Medicine
- 2005 - 2011 Chiba University School of Medicine
Work history (6)：
Association Membership(s) (4)：
日本分子生物学会
, 日本癌学会
, 日本内科学会
, 日本臨床腫瘍学会
